Acyl derivatives of glycosyl-L-ascorbic acid

Details Acyl derivatives of glycosyl-L-ascorbic acid Acyl derivatives of glycosyl-L-ascorbic acid

1999-03-03

2001-06-19

Tsang, Cecilia (Department: 1623)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C514S474000

Reexamination Certificate

active

06248905

ABSTRACT:

BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to an oil-soluble derivative of a glycosyl-L-ascorbic acid, and more particularly to an acyl derivative of a glycosyl-L-ascorbic acid.
2. Description of the Prior Art
Vitamin C or L-ascorbic acid, an anti-scorbutus factor, has been widely used as a specific medicine for scorbutus. At present, it is revealed that vitamin C deeply correlates to hydroxyl reactions in vivo, for example, the biosynthesis of collagen, the metabolism of aromatic amino acids, and the formation of adrenalin in the adrenal; and it also plays an important role in the detoxification system for external invaders in the liver. Because of these diversified physiological activities, a quantity of L-ascorbic acid is consumed annually in the food-, cosmetic-, and pharmaceutical-fields.
As it is well known, unlike other vitamins, L-ascorbic acid is a relatively-highly unstable substance easily decomposed or denatured by heat, light, oxygen, metal ions, etc. Therefore, users must use L-ascorbic acid in a higher amount that far exceeds a theoretical level, and must pay close attention to the storing and handling of the compound. Also there exists a problem that L-ascorbic acid could not reach the desired tissues in a desired effective amount because it is not oil-soluble and the permeation to the tissues is inhibited by fat components when applied to in vivo tissues such as skin and mucosas rich in fat components. To overcome these drawbacks, many efforts have been made to convert L-ascorbic acid into its acid esters and glycosyl compounds.
Although conventional fatty acid esters such as 2-stearyl-L-ascorbic acid, 6-palmityl-L-ascorbic acid, and 2,6-dipalmityl-L-ascorbic acid have an improved oil-solubility oven intact L-ascorbic acid, these esters do not release L-ascorbic acid in vivo and could not exert the important physiological actions of L-ascorbic acid. Similar to intact L-ascorbic acid, inorganic esters of L-ascorbic acid such as phosphates and sulfates of L-ascorbic acid have the following problems; they are not oil-soluble, and in particular, these sulfates and fatty acid esters do not release L-ascorbic acid in vivo.
Glycosyl-L-ascorbic acids such as 2-O-glucopyranosyl-L-ascorbic acid and 2-O-galactopyranosyl-L-ascorbic acid, as disclosed in Japanese Patent Kokai Nos. 139,288/91, 135,992/91, 183,492/91, 228,183/94, and 263,790/94, are substances that were explored to overcome the drawbacks of L-ascorbic acid. These L-ascorbic acid derivatives have no reducing group within their molecules so that they have an extremely-high tolerance to heat, light, oxygen, and metal ions, and have a character of easily releasing L-ascorbic acid in vivo. Depending on use, the conventional L-ascorbic acid derivatives, however, have drawbacks similar to L-ascorbic acid due to their non-oil-solubility.
L-Ascorbic acid is a natural compound distributed widely in plants and animals, and is present in animals' adrenals and citrus fruits, and therefore it can be advantageously used in food products, cosmetics, and pharmaceuticals with lesser side effects. Recently, radicals formed in living bodies are known as a factor for life-style related diseases or geriatric diseases, in this regards L-ascorbic acid is said to have an activity of entrapping radicals in vivo and is capable of preventing the generation of tumor cells. It is highly speculated that the demands and uses of L-ascorbic acid will be widened more and more.
SUMMARY OF THE INVENTION
In view of the foregoing, the object of the present invention is to provide an oil-soluble substance that releases L-ascorbic acid in vivo, a process for producing the same, and uses thereof.
The present inventors continuously studied to solve the above object. As a result, they found that acyl derivatives of glycosyl-L-ascorbic acids are oil-soluble and capable of smoothly releasing L-ascorbic acid in vivo. They also found that the acyl derivatives can be easily produced in the desired amount by reacting glycosyl-L-ascorbic acids with acylating agents, and confirmed that the derivatives can be arbitrarily used in the fields of food products, cosmetics, and pharmaceuticals because of their outstanding properties. Thus, the present inventors accomplished this invention.
The present invention solves the above object by providing acyl derivatives of glycosyl-L-ascorbic acids.
The present invention solves the above object by providing a process for producing acyl derivatives of glycosyl-L-ascorbic acids, characterized in that it comprises a step of reacting glycosyl-L-ascorbic acids with acylating agents.
The present invention solves the above object by providing food products which contain the acyl derivatives of glycosyl-L-ascorbic acids.
The present invention solves the above object by providing cosmetics which contain the acyl derivatives of glycosyl-L-ascorbic acids.
The present invention solves the above object by providing pharmaceutical compositions for L-ascorbic acid-susceptive diseases, which contain the acyl derivatives of glycosyl-L-ascorbic acids.
BRIEF EXPLANATION OF THE ACCOMPANYING DRAWINGS
FIG. 1
is a figure that shows the stability of L-ascorbic acid, 2-O-&agr;-D-monoglucopyranosyl-L-ascorbic acid, and the present acyl derivative in an aqueous solution at 60° C.
FIG. 2
is a figure that shows the stability of L-ascorbic acid, 2-O-&agr;-D-monoglucopyranosyl-L-ascorbic acid, and the present acyl derivatives in an aqueous solution at 37° C.
FIG. 3
is a figure that shows the time course of the blood level of L-ascorbic acid in rats administered with 2-O-&agr;-D-monoglucopyranosyl-L-ascorbic acid, and the present acyl derivatives.
FIG. 4
is a figure that shows the dynamics in the blood level of the present 6-Octa-AA-2G in rats administered with the compound intravenously, and the change of the metabolized products of the compound.
FIG. 5
is a figure that shows the time course in the blood level of L-ascorbic acid, 2-O-&agr;-D-monoglucopyranosyl-L-ascorbic acid, and the present 6-Octa-AA-2G in rats administered with the compounds intravenously.
FIG. 6
is a figure that shows the time course of the dynamics of L-ascorbic acid, 2-O-&agr;-D-monoglucopyranosyl-L-ascorbic acid, the present acyl derivatives when permeating into an artificial skin.
FIG. 7
is a figure that shows the dynamics of the release of L-ascorbic acid and 2-O-&agr;-D-monoglucopyranosyl-L-ascorbic acid when permeating into an artificial skin.
FIG. 8
is a figure that shows the dynamics of L-ascorbic acid, 2-O-&agr;-D-monoglucopyranosyl-L-ascorbic acid, and the present acyl derivatives when releasing L-ascorbic acid and 2-O-&agr;-D-monoglucopyranosyl-L-ascorbic acid within an artificial skin.
FIG. 9
is a figure that shows the change in the body weight of guinea pigs with scorbutus when administered with water, 2-O-&agr;-D-monoglucopyranosyl-L-ascorbic acid, and 6-Octa-AA-2G.


REFERENCES:
patent: 5122536 (1992-06-01), Perricone
patent: 5658957 (1997-08-01), Martin
patent: 5767095 (1998-06-01), Winget
patent: 5891452 (1999-04-01), Sebillote-Arnaud et al.
patent: 0398484 (1990-11-01), None
patent: 0425066 (1991-05-01), None
patent: 0627441 (1994-12-01), None
patent: 0425066 (1995-05-01), None
patent: 2715565 (1995-08-01), None
patent: 6228183 (1994-08-01), None
patent: 6263790 (1994-09-01), None
patent: 9742960 (1997-11-01), None
Summary of 118th Pharmaceutical Society of Japan, Kyoto, Japan, published on Mar. 5, 1998.
Yamamoto, I. et al., “Antiscorbutic Activity of L-Ascorbic Acid 2-Glucoside and Its Availability as a Vitamin C Supplement in Normal Rats and Guinea Pigs,” J. Pharmacobio-Dyn., 13,688-695(1990).
Szarek et al., “Conjugation of L-ascorbic acid and D-glucose”,Carbohydr. Res., vol. 67, pp. C13-C16, (1978).

Affiliated with

Also associated with

Rating

Acyl derivatives of glycosyl-L-ascorbic acid does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Acyl derivatives of glycosyl-L-ascorbic acid, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acyl derivatives of glycosyl-L-ascorbic acid will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2482521